Skip to main content
爱得科技 logo

爱得科技 — Investor Relations & Filings

Ticker · 920180 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 33 across all filing types
Latest filing 2026-03-02 Governance Information
Country CN China
Listing Beijing Stock Exchange 920180

About 爱得科技

http://www.andtosi.com/

Aide Medical Technology specializes in the research, development, and manufacturing of orthopedic medical devices. The company provides a comprehensive portfolio of surgical solutions, including spinal fixation systems, trauma internal fixation systems, and joint replacement products. Its product range extends to specialized surgical instruments designed to enhance clinical outcomes. By integrating advanced manufacturing processes with rigorous quality control standards, the company delivers high-performance implants for complex orthopedic procedures. Aide Medical Technology focuses on continuous innovation to address evolving clinical needs in bone repair and reconstruction, serving a global network of healthcare providers and medical institutions.

Recent filings

Filing Released Lang Actions
子公司管理制度
Governance Information Classification · 95% confidence The document is titled '苏州爱得科技发展股份有限公司子公司管理制度' which translates to 'Subsidiary Management System of Suzhou Aide Technology Development Co., Ltd.' It details the company's internal rules and procedures for managing its subsidiaries, including governance, operational control, reporting, auditing, and compliance with laws and stock exchange rules. The document includes the approval by the board of directors and voting results. It is a governance-related policy document rather than a financial report, earnings release, or announcement of voting results. It does not contain financial statements or audit opinions. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2026-03-02 Chinese
2025年年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a '2025 Annual Performance Express Report' and contains preliminary financial data for the full year 2025, including revenue, net profit, and asset figures. It explicitly states that the data are preliminary and unaudited, with final audited figures to be disclosed in the formal 2025 Annual Report. The document is relatively short (1593 characters) and serves as an initial earnings summary rather than a full comprehensive report. This matches the characteristics of an Earnings Release (ER), which provides key highlights of quarterly or annual financial results before the full report is published. Therefore, the document should be classified as an Earnings Release (ER). FY 2025
2026-02-26 Chinese
关于签署募集资金三方及四方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of three-party and four-party supervision agreements related to the company's fundraising activities. It details the issuance of shares to qualified investors, the amount raised, the establishment of special accounts for the raised funds, and the supervisory roles of involved parties. The document does not contain financial statements or detailed financial performance data but focuses on the regulatory and procedural aspects of fundraising and fund management. The length is 4123 characters, which is relatively short and the content is an announcement of agreements related to capital raising rather than the capital raising report itself. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2026-02-11 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.